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Objective: The incidence of venous thromboembolism (VT) after aortic abdominal aneurysm (AAA) surgery is imprecisely
reported. On one hand, thromboprophylaxis has improved, on the other hand, AAA patients have become older and/or
present worse comorbidities. Herein, we prospectively analyzed the incidence of VT in a continuous series of patients
operated on for AAA repair and looked for predictive factors.
Materials and Methods: Between January 1, 2005, and December, 31, 2006, 193 consecutive patients (177 men and 16
women), mean age 73 (range, 47-93) underwent elective AAA repair, 137 open (71%) and 56 endovascular (29%), in our
institution. Thromboprophylaxis consisted of thigh-length compression bandages or stockings, early mobilization, and
a daily subcutaneous injection of low-molecular-weight heparin (enoxaparin 40 mg per day). Patients with renal
insufficiency or aged over 80 were given unfractionated heparin (5000 IU twice a day). Heparin was started between day
1 and day 5 (median  day 1) after surgery, according to the prescription of the surgeon. A bilateral lower limb duplex
venous compression ultrasonography scan using 3 to 7.5 MHz transducers was systematically done before and after
surgery in each patient. Two groups were considered: group 1 with postoperative VT (n  17) and group 2 without
(n  176). The 17 patients with VT were compared with 51 patients randomly chosen among the 176 patients without
VT. Different characteristics such as venous risk factors, preoperative antithrombotic treatment, anatomical features of
the AAA, and perioperative data were studied.
Results: Seventeen patients (8.1%) were diagnosed with postoperative VT (15 asymptomatic deep vein thrombosis [DVT]
and 2 symptomatic pulmonary embolisms [PE]). VTE tended to be more frequent in open (10.2%) than endovascular
(5.3%) repair (P  .28). Among perioperative data, delay to thromboprophylaxis was related to bleeding complication
(P  .05) and blood transfusion (P  .02), and tended to be longer in VT patients (1.7 / 1.4 vs 0.9 / 0.9 day;
P  .09).
Conclusion:Despite systematic prevention with heparin, surgery for AAA repair induces a high incidence of postoperative
VT. This series mandates for vigilance about VT, with particular attention to the patients who received transfusion with
fresh frozen plasma. Even though this series is one of the largest ever published on this topic, the rarity of the events calls
for confirmation with a larger prospective study. (J Vasc Surg 2009;49:596-601.)Venous thromboembolism (VT) frequently occurs in
hospitalized patients and especially after surgery. Some
major surgical procedures are known to be associated with
a high risk of developing VT. For example, in major ortho-
pedic surgery 65% of patients developed VT in the control
arm without thromboprophylaxis.1 Through a tremendous
effort in prevention, the use of routine pharmacological and
mechanical devices led to a threefold reduction in the
incidence of deep venous thrombosis (DVT) and pulmo-
nary embolism (PE) after elective hip and knee joint sur-
gery.2,3 In a recent prospective study, a VT incidence of
1.34% (95% confidence interval [CI], 1.04–1.64) was ob-
served after surgery for hip fracture, despite the use of
thromboprophylaxis.4 There are fewer reports concerning
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596VT following vascular surgery, and in our practice we
noticed that aortic abdominal aneurysm (AAA) repair gen-
erated some postoperative venous thrombotic events. At
the time of surgery, vascular patients in general, and AAA
patients in particular, tend to be older with more debilitat-
ing comorbidities, leading to a higher risk for venous
complications. Despite this, no recommendations have
been clearly established.
OBJECTIVE
To prospectively analyze the incidence of VT in a
continuous series of patients operated on for AAA repair
and to look for predictive factors in order to improve the
perioperative prevention of venous thrombosis.
MATERIALS AND METHODS
Between January 1, 2005, and December 31, 2006,
193 consecutive patients underwent elective AAA repair in
our department, 137 open (71%) and 56 endovascular
repairs (29%). There were 177 men and 16 women. The
mean age was 73 years, ranging from 47 to 93.
During surgery, all patients received a heparin bolus of
0.5 mg/kg (50 IU/kg) before clamping. Biological mon-
itoring by activated coagulation time (ACT) was performed
in case of surgery longer than 2 hours and additional bolus
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(ratio 1:1) at the end of the operation.
Thromboprophylaxis consisted of thigh-length com-
pression bandages or stockings, early mobilization, and a
daily subcutaneous injection of low-molecular-weight hep-
arin (LMWH) (enoxaparin 40 mg per day).5 The regimen
of 40 mg daily has been recommended for high-risk situa-
tions of venous thrombosis by the latter American College
of Chest Physicians (ACCP) consensus, the only men-
tioned study with LMWH after vascular surgery concerned
enoxaparin 40 mg (4000 IU).6 Patients with renal insuffi-
ciency or those over 80 years of age were given unfraction-
ated heparin (UH) (5000 IU, twice a day). When needed,
UH was chosen in a moderate dose to prevent VT but also
postoperative bleeding. Anticoagulation was started be-
tween day 1 and day 5 (median  day 1) after surgery,
according to the prescription of the surgeon (Fig). Me-
chanical prophylaxis consisted of compression bandages
(Bandage Biflex 16, Thuane, France), in case of varicose
veins (20% of the patients), and stockings (TED, Codiven,
United Kingdom) otherwise, without crossover. The com-
pression program was applied by nurses: bandages 20 to 25
mm Hg and stockings 12 to 15 mm Hg. Compression
devices were worn continuously during the whole hospital
stay. Mobilization consisted of bed to chair at day 1 and
ambulation as of day 2.
Venous duplex scan was performed during the system-
atically scheduled ultrasonic arterial examination the day
before surgery and once before discharge (median time:
day 2 after endovascular repair and day 6 after open sur-
gery) or anytime in case of clinical suspicion of DVT. It
consisted in a bilateral lower limb duplex venous compres-
sion ultrasonography scan using 3 to 7.5 MHz transducers
by a team of experienced practitioners from the Depart-
ment of Angiology. The venous ultrasonography examina-
tion used high definition imaging equipment and consisted
of imaging the venous segments without and with com-
pression. The inferior cava, bilateral iliac, femoral (com-
mon, superficial, and profunda), and popliteal veins were
Fig. Timing of heparin onset in the postoperative period of the
whole series of AAA patients.checked in the supine position and the bilateral calf veinsincluding posterior tibial, peroneal, gastrocnemial, and
solear, in the sitting position. Venous thrombosis was de-
fined as the presence of endoluminal material with a diam-
eter on compression 5 mm.7
The study population was divided in two groups: group
1 with postoperative VT and group 2 without VT. The 17
group 1 patients were compared to controls chosen among
patients from group 2. Three controls were randomized
and chosen for each case (51 controls for 17 cases). Regard-
ing anticoagulation prevention, among the 17 VT cases, 12
received enoxaparin 40mg, and 5 preventive UH. In group
2, 38 patients were treated with enoxaparin 40 mg, 8 with
preventive UH, and 5 with curative UH (patients on oral
anticoagulant [OAC] for atrial fibrillation). Patients were
kept on aspirin during the surgery period and those who
received clopidogrel were switched to aspirin in order to
decrease the risk of bleeding.
Different characteristics were studied: previous episode
of DVT, concurrent malignant disease, history of cardio-
vascular events, overweight (body mass index25), preop-
erative treatment with antiplatelet drugs (aspirin, clopi-
dogrel), or anticoagulants (coumadin), anatomical features
(maximum diameter of the AAA, and the presence of
thrombus in the aneurismal sac), perioperative data (oper-
ative time, clamping time, estimated blood loss, use of
blood products (packed red blood cells [PRBC], platelets,
fresh frozen plasma [FFP], postoperative data (first day of
LMWH prescription).
The high incidence of thrombotic events led us to look
for risk factors and to bring additional data compared to
previous studies. Our study is only explanatory, as no factor
was known sufficiently to allow computation of a sample
size on a power basis. The data were evaluated by 2 analysis
for categorical data and the Mann-Whitney U test for
continuous data. In the tables, data are expressed with
mean values and standard deviations (SD). A P value .05
was regarded as statistically significant.
This investigation has been included in a research pro-
gram focused on AAA, and was approved by the ethics
committee of our academic hospital (reference: AOI
2003). No patient was asked to sign an informed consent
form because neither additional examination nor extra
blood sampling was requested for this study.
RESULTS
No patient was diagnosed with VT in the preoperative
period. Five patients had a past history of VT (6 months).
Seventeen patients (8.1%) were diagnosed with postopera-
tive VT consisting of 15 asymptomatic DVT and 2 symp-
tomatic PEs. One patient presented with acute dyspnea and
chest pain 2 days after open AAA repair. Diagnosis of PE
was confirmed by computed tomography (CT)-scan, and
one asymptomatic bilateral distal DVT was discovered on
the duplex scan. Even though the patient presented with
bleeding complications at day 0 and had received a blood
transfusion (3 PRBC and 1 FFP), a daily administration of
40mg enoxaparin was started as soon as day 1 after surgery.
No venous risk factors were highlighted. The second symp-
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following the operation and was diagnosed with bilateral
asymptomatic DVT, distal in the right leg, proximal in the
left leg. He had undergone open AAA repair with no
bleeding or need for a blood transfusion. He had also
received a daily injection of 40 mg of enoxaparin, since the
day following the operation. This patient was found to have
two venous risk factors: prior DVT after previous orthope-
dic surgery and obesity (body mass index  34). The 15
asymptomatic VT patients had proximal DVT (femoro
popliteal) in 2 patients, distal DVT in 12 patients, and a
superficial VT in a saphenous vein.
VT seemed to be more frequent in open (10.2%) than
endovascular (5.3%) repair, but the difference was not
significant (P  .28). The VT risk factors are presented in
Table I. Preoperative data did not allow identification of
patients at risk. No significant difference was observed for
patients with a history of DVT, concurrent malignant dis-
Table I. Perioperative data in patients undergoing AAA p
No thro
(51 pat
Preoperative data
Age (years) 72.5 (7
BMI 26.3 (4
Cardiovascular history (n  40) 60.7
Prior venous thrombosis (n  5) 5.9
AAA anteroposterior diameter (mm) 58.1 (1
Preoperative antiplatelet treatment (n  43) 34.0
Preoperative anticoagulant treatment (n  9) 86.2
Surgery
Time of surgery (mn) 167 (5
Time of clamping (mn) 59.2 (2
Estimated blood loss (mL) 1300 (1
Time in intensive care unit
Number of days 2.6 (4
2 days 25.4
Delay to start of thromboprophylaxis
Number of days 0.9 (0
1 day 20.0
Blood product transfusion
Red blood cells
- %
43.1
- nb of products 1.4 (1
Fresh frozen plasma
- %
9.8
- nb of products 0.3 (1
Platelet concentrate
- %
5.9
Hemogram
Hb (g/dL)
- preoperative 13.8 (1
- postoperative 10.2 (1
Platelets (g/L)
- preoperative 228 (5
- postoperative 140 (3
Fibrinogen (g/L)
- preoperative 3.6 (0
- postoperative 2.0 (0
AAA, Aortic abdominal aneurysm.
*Results are expressed as mean (SD: standard deviation) or %.ease, cardiovascular disease, or overweight. Before surgery,9 patients were on oral anticoagulation and 43 on an
antiplatelet drug. Even though our policy was to maintain
aspirin and discontinue clopidogrel for 7 days before sur-
gery, antiplatelet drugs were found to have no incidence of
thrombotic complications. Anatomic features such as AAA
anterior to posterior diameter and the presence of a throm-
bus in the aneurysm sac were not predictive of VT either.
Neither were operative data such as operating time, clamp-
ing time, and estimated blood loss. VTE patients seemed to
stay in the intensive care unit (ICU) longer than did
non-VT patients (3.7 / 4.2 days vs 2.6 / 4.5 days,
P .6), but the difference was not significant. The delay to
LMWH prescription tended to be longer in VT patients,
compared to non-VT patients (1.7 / 1.4 days vs 0.9
/ 0.9 days, P .09). At day 1 after surgery, 65% of the
VT patients and 80% of the non-VT patients were already
being given LMWH. The delay to heparin prescription was
related to a higher blood loss during the first 24 hours (P
ure with and without postoperative thrombosis*
s Thrombosis
(17 patients)
P
Mann-Whitney
P
2
73.2 (7.1) 0.69
27.9 (4.4) 0.27
52.9% 0.77
11.7% 0.59
56.1 (10.2) 0.60
41.1% 0.77
8.2% 1
161 (83) 0.30
67.1 (33.1) 0.59
1160  (855) 0.81
3.7 (4.2) 0.60
41.1% 0.36
1.7 (1.4) 0.09
35.3% .32
48.8 0.40
3.3 (3.8) 0.07
35.2 0.02
1.2 (1.8) 0.01
17.6 0.32
13.8 (0.9) 0.94
9.7 (1.3) 0.14
212 (37) 0.36
125 (37) 0.21
3.7 (0.6) 0.52
1.9 (0.5) 0.80roced
mbosi
ients)
.2)
.5)
%
%
4.6)
%
%
1)
4.8)
100)
.5)
%
.9)
%
.9)
.0)
.5)
.5)
9)
6)
.7)
.5).005) and transfusion of blood products, either PRBC or
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statistically related to the occurrence of VT (P  .02). The
transfusion intensity of PRBC (P  .07) but not the
percentage of transfused patients (P  .40) was associated
with VT complications. A very small number of patients
required platelet transfusion.
There was neither pertinent information obtained from
the perioperative hemogram charts, nor argument for a
chronic disseminated intravascular coagulopathy. After sur-
gery, an almost 40% drop in hemogram values and in
fibrinogen levels due to bleeding and hemodilution were
observed in both groups.
DISCUSSION
This study was conducted over a 2-year period in order
tomeet enough thrombotic events. Even if the correspond-
ing control number was limited, the time necessary to study
all of them was out of reach. Our retrospective search for
VT risk factors with a case control study was then settled on
an objective selection of the controls by randomization
(done by a statistician) giving representative controls.
No recommendations concerning thromboprophylaxis
have been clearly established for patients undergoing aortic
surgery, although this setting could be considered high-risk
for VT. These patients gather several risk factors including
advanced age, limb ischemia, long duration of surgery, and
intraoperative local trauma, including possible venous in-
jury.8 The incidence of clinically overt VT occurring during
the hospital stay or requiring re-hospitalization within 3
months after surgery is 2.5 to 2.9%.9 The incidence of
Table II. Relation between blood loss, transfusion, and d
Delay to heparin
prevention 24 hours
Estimated blood loss
- total (mL) 1040 (1040)
- 1 liter 29.4%
Transfusion of blood
products
Red blood cells
- % 39.2
- nb of concentrates 1.3 (2.1)
Fresh frozen plasma
- % 9.8
- nb of concentrates 0.3 (1.0)
Table III. Incidence of venous thrombosis (by duplex US
Lower limb examination n Postoperati
Farkas15 duplex US 75 UFH
Fletcher16 duplex US 52 UFH
Eagleton14 duplex US 50 UFH
Killewich13 duplex US 88 UFH
Present study duplex US 193 LMW
AAA, Aortic abdominal aneurysm; DVT, deep vein thrombosis; US, u
low-molecular-weight heparin.asymptomatic VT varies widely, ranging from 2% to 41%,and depends firstly on the diagnostic method used and
secondly on the presence or not of prophylaxis.10 In five
prospective studies of vascular surgery patients not receiv-
ing thromboprophylaxis, the pooled rate of postoperative
DVT was 21% (18 out of 86 patients) using contrast
venography11-13 and 15% (15 out of 98 patients) using
Doppler ultrasonography scan.14,15 Asymptomatic DVT
after aorto iliac or aorto femoral surgery would be similar to
that reported in other abdominal and pelvic procedures.9
There are few studies specifically done on DVT after AAA
surgery (Table III).12,14,16 Aortic aneurysm resection or
aortofemoral bypass appears to confer a higher risk of DVT
than does femoro-distal bypass. More recently, Hollyoak et
al14 reported the results of a pre-hospital discharge duplex
ultrasound (DUS) study of 50 vascular patients without
thromboprophylaxis, and showed a higher rate of DVT in
aortic surgery patients (41%) compared to patients under-
going peripheral artery surgery (18%). Farkas et al17 ran-
domized patients to receive either a low subcutaneous dose
of UH or LMWH following vascular surgery. Using DUS
screening at 7 to 10 days after surgery, with venography
confirmation of a positive DUS result, DVTwas detected in
8% of patients (11 out of 146) who underwent aortic
surgery and in 3% of those who underwent femoro-distal
bypass (3 out of 87). Fletcher et al18 published a routine
DUS study in vascular surgery patients who received pro-
phylaxis with intermittent pneumatic compression associ-
ated with low dose unfractionated heparin (LDUH). The
incidence of DVT among patients undergoing aortic sur-
gery or femoro-distal bypass was 12% (6 out of 52) and 9%
o start of thromboprophylaxis
Delay to heparin
prevention 24 hours
P
Mann-Whitney
P
2
1850 (821) 0.005
76.9% .007
75 0.02
3.6 (3.5) 0.006
7.5 0.02
1.3 (1.9) 0.01
er AAA surgery despite thromboprophylaxis
ticoagulant prophylaxis Total DVT (%) Proximal DVT (%)
H 7.5 2.7
11.5 6.3
eoperative OAC) 6 6
— 2
8.5 1.5
und; UFH, unfractionated heparin; OAC, oral anticoagulant; LMWH,elay t) aft
ve an
/LMW
(if pr
H
ltraso(5 out of 54 patients), respectively. A prospective registry
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tomatic DVT after aortic surgery and 0.7% after femoro-
distal reconstruction. In the present study, the incidence of
DVT was found to be 9.5%, 1% symptomatic, and 8.5%
asymptomatic, which is in accordance with the literature.
Unlike Eagleton et al, we did not observe a significant
difference between the two techniques of AAA treatment
but endovascular presented less DVT than open repair
(5.3% vs 10.2%; P  .28). Nevertheless, both patients who
presented symptomatic PE were treated with open surgery.
Furthermore, some DVT were limited to the calf, a feature
that was not encountered in Eagleton’s series, even though
all our patients were examined with DUS only. Systematic
duplex scan examination is not recommended after surgery,
but the question remains unanswered.
Different data that could be considered as potential risk
factors for VT were assessed. The delay between the end of
the operation and the first injection of antithrombotic
drugs was found to be significantly longer in the VT group
(1.7 days vs 0.9 days, P  .09). This delay could be
explained by bleeding (P  .05) and by the need for the
transfusion of blood products (P  .02), which made
surgeons cautious about prescribing a VT prophylaxis in-
jection the same day. The occurrence of VT was related to
the transfusion of FFP, but not to that of PRBC. These data
reflect together that intensive transfusion could represent a
predictive risk factor of VT, and one explanationmay be the
delay for the beginning of heparin treatment (administra-
tion of FFP when four or more units of PRBC were
transfused). No patient was excluded for any reason in this
continuous series, even if a prescription delay may have
been involved in the VT occurrence. These data could
advise us to start thromboprophylaxis as soon as possible
after the end of the operation, and as much as possible the
same day, even in the presence of bleeding. Other prophy-
lactic methods such as intermittent calf compression and
elastic compression stockings should be considered system-
atically during the whole hospital stay, but were only used
intermittently in our series, after ICU discharge. Throm-
botic events were observed early after surgery (day 2 for
both symptomatic PE and first postoperative week for
asymptomatic VT). Further studies should take account of
these data. Occurrence of postoperative VT could be re-
lated to other causes, such as activation of coagulation by
aneurysmal disease (reported chronic disseminated intra-
vascular coagulation). Some of the thrombotic complica-
tions may stem from the underlying aneurysmal disease.
The development of AAA is known to be associated with
local activation of coagulation.19 Leukocyte recruitment is
promoted by proinflammatory cytokines and locally pro-
duced chemokines. The mural thrombus in the aneurysm
sac could also play a role in trapping and releasing leuco-
cytes, platelets, proteases, and plasminogen and its activa-
tors.20 A state of activation of both coagulation and fibri-
nolysis was found in AAA patients before surgery.21,22 The
Cochrane collaboration study recently reviewed published
studies about anticoagulant prevention with or without
mechanical devices in AAA surgery. Systematic thrombo-prophylaxis was not recommended but the conclusions
were based on only two relevant studies.15,23,24 The first
study done in the 70s was stopped after only 50 inclusions
out of 150 planned because of bleeding complications, but
surgical techniques have been improving for the last 30
years. The second study included 98 patients divided in two
groups (with or without heparin treatment). Only one
thrombotic event (2%) occurred in each group. The low
incidence of VT could be explained by the absence of
venous examination in the calf. It must be noticed that one
person diagnosed a DVT, eventually developed a PE. The
1% incidence of symptomatic PE should not be neglected
and further studies with larger population are needed to
conclude.
CONCLUSION
In conclusion, surgery for AAA induces a high inci-
dence of postoperative VT, despite systematic prevention
with heparin. In our series, the transfusion of blood prod-
ucts was found to be predictive of developing postoperative
VT complications, and a tendency was observed with the
delay to the first injection of antithrombotic agent. Coag-
ulation activation has been reported in patients presenting
with AAA and this setting could also predispose patients to
VT but has not been explored in this study. Most events
were asymptomatic, but the 1% incidence of symptomatic
VT in this study should lead us to optimize thrombopro-
phylaxis after aortic surgery; indeed this 1% incidence is
close to the residual incidence of VT after major orthopedic
surgery. Even though this series is one of the largest ever
published on this topic, the rarity of the events calls for
confirmation with a larger prospective study.
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